We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Please delete this page upon discussion or finalisation of document]Master Clinical Trial Agreement • January 3rd, 2024
Contract Type FiledJanuary 3rd, 2024The clauses in this Master Clinical Trial Agreement (MCTA) have been reviewed and agreed by legal representatives from Singapore Association of Pharmaceutical Industries (SAPI), Singapore Health Services (SingHealth), National Healthcare Group (NHG) and National University Health System (NUHS) with the aim to expedite agreement review process between Sponsor and Singapore’s Public Healthcare Institutions.
Please delete this page upon discussion or finalisation of document]Master Clinical Trial Agreement • October 14th, 2022
Contract Type FiledOctober 14th, 2022The clauses in this Master Clinical Trial Agreement (MCTA) have been reviewed and agreed by legal representatives from Singapore Association of Pharmaceutical Industries (SAPI), Singapore Health Services (SingHealth), National Healthcare Group (NHG) and National University Health System (NUHS) with the aim to expedite agreement review process between Sponsor and Singapore’s Public Healthcare Institutions.